Indy Hematology Review

http://www.indyhematologyreview.com/

 

Indy Hematology Review
R

Current and Emerging Therapies for AML and MDS

By Indy Hematology Review FEATURING Richard Larson
By Indy Hematology Review FEATURING Richard Larson
81 views
April 19, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

11:12
Stemline

A proven CD123 targeted therapy for BPDCN

Feat. H. Erba

Featured Video

19:39
Pfizer Hematology

Making the First Chance Count: Manuel

Feat. A. Ip
2023
19:34

2023 Management of Long-Term Survivors of Hematologic Malignancies

Indy Hematology Review

S. Garofalo

66 views
26:05

Understanding and Managing Immune Effector Cell Toxicities in Hemato…

Indy Hematology Review

D. Reeves

76 views
73:56

Indy Hematology Review 2023: Expert Case Discussions

Indy Hematology Review

M. Wiemann, S. Usmani, J. Mikhael, M. Lunning, S. Treon, T. Phillips, J. Woyach

83 views
21:29

Indy Hematology Review 2023: Emerging Therapies in Hematologic Malig…

Indy Hematology Review

R. Birhiray

71 views
24:53

Emerging and Current Treatment of Amyloidosis and Waldenstrom’s Macr…

Indy Hematology Review

M. Gertz

209 views
26:02

Recognizing Toxicities of Oral Oncolytics in the Management of Hemat…

Indy Hematology Review

K. Orbaugh

34 views
31:33

Sickle Cell Disease and Clotting Disorders of the Blood in 2023

Indy Hematology Review

C. Kessler

103 views
31:51

Managing Newly Diagnosed MM in 2023

Indy Hematology Review

S. Usmani

250 views
22:30

Targets and Treatments of MPNs in 2023

Indy Hematology Review

R. Mesa

332 views
32:06

Current and Emerging Therapies for AML and MDS

Indy Hematology Review

R. Larson

81 views
24:33

Therapeutic Options in CLL in 2023: Choosing the Initial Therapy Wis…

Indy Hematology Review

J. Woyach

1.2K views
31:25

Jumping on a Moving Bullet Train: Emerging Treatments for Hodgkin Ly…

Indy Hematology Review

M. Lunning

75 views
34:28

Advancing Therapeutic Outcomes in Aggressive B and T Cell Lymphomas

Indy Hematology Review

T. Phillips

135 views
19:42

Beyond Hyperviscosity: 80 Years and Counting - Treatment of Waldenst…

Indy Hematology Review

S. Treon

33 views
18:27

DEBATE: Why Not to Transplant When MRD Has Been Achieved After Initi…

Indy Hematology Review

J. Mikhael

545 views
15:53

DEBATE: Transplanting the MRD- Myeloma Patients for a Deeper Remissi…

Indy Hematology Review

S. Usmani

335 views
06:33

Indy Hematology Review 2023: Take Home Messages for MDS & AML

Indy Hematology Review

R. Komrokji

99 views
06:36

Indy Hematology Review 2023: Recent Important Results for Adult ALL

Indy Hematology Review

C. Schiffer

71 views
04:15

Indy Hematology Review 2023: Plasma Cell Neoplasms and Amyloidosis U…

Indy Hematology Review

M. Gertz

714 views
28:07

Controversies and Recommendations for the Treatment of ALL and Lymph…

Indy Hematology Review

W. Stock

634 views
38:55

Managing Indolent and Mantle Cell Lymphomas With Targeted and Cellul…

Indy Hematology Review

G. Salles

154 views
24:21

Emerging Therapies for R/R CLL

Indy Hematology Review

W. Wierda

97 views
31:43

Myelofibrosis: Chronic and Blast Phase - 2023 Algorithms for Risk St…

Indy Hematology Review

A. Tefferi

776 views
24:37

Recent Updates on the Treatment of Polycythemia Vera

Indy Hematology Review

A. Fleischman

375 views
16:23

Updates on the Treatment of Myelofibrosis and FGFR-Mutated Myeloid N…

Indy Hematology Review

A. Fleischman

224 views
32:03

Emerging and Current Treatment of MM: What Should We Know and What S…

Indy Hematology Review

K. Anderson

652 views
31:16

Hematopoietic Stem Cell Transplantation: State of the Art in 2023

Indy Hematology Review

R. Childs

85 views
28:25

Managing the Benign Hematology Consult: Treatment Recommendations fo…

Indy Hematology Review

C. Kessler

1.1K views
28:41

Improving Outcomes With Current Therapies in AML and Acute Promyeloc…

Indy Hematology Review

M. Tallman

66 views
27:52

The Oracle of Apollo in Indianapolis: Prognosis and Treatment in MDS

Indy Hematology Review

R. Stone

298 views
27:16

Resistant or Recurrent CML and Prospective Discontinuation

Indy Hematology Review

R. Larson

59 views